NCT07469020 CLE-PAD : Prevalence of PAD in Patients With Surgically Lumbar Spinal Stenosis
| NCT ID | NCT07469020 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Rennes University Hospital |
| Condition | PAD - Peripheral Arterial Disease |
| Study Type | INTERVENTIONAL |
| Enrollment | 49 participants |
| Start Date | 2026-08 |
| Primary Completion | 2026-08 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.
This trial targets 49 participants in total. It began in 2026-08 with a primary completion date of 2026-08.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
The goal of this interventional study is to evaluate the rate of existing lower limb peripheral artery disease (PAD) in patients with surgically lumbar spinal stenosis (LSS). PAD and LSS can present similar symptoms and it can be difficult to diagnose PAD using conventional methods, depending on the location of the arterial disease. The main questions it aims to answer are : * What's the prevalence of PAD in LSS patients? * Which exam among routine tools is the most accurate to diagnose PAD in this population? Around their surgery for LSS (a few weeks before or after), participants will be included in a vascular medicine service. After checking of eligibility criteria, they will undergo a contrast-enhanced CT scan for the diagnosis of PAD and various routine diagnostic tests: Doppler ultrasound, treadmill tests, pressure index, pulse palpation.
Eligibility Criteria
Inclusion Criteria: * Presenting with a lumbar spinal stenosis with surgical indication, either unoperated or operated on less than 3 months ago * Affiliated with a social security scheme * Having received oral and written information about the protocol and having signed a written consent form to participate in this research. Exclusion Criteria: * emergency surgical care * Contraindication to contrast enhanced CT scan * Stroke or myocardial infarction (MI) within the last 3 months * Known severe or poorly tolerated arrhythmia * Known severe or symptomatic left ventricular outflow obstruction * Decompensated heart failure * History within the last 3 months of venous thromboembolic disease, myopericarditis, endocarditis, aortic dissection or intracardiac thrombus * Severe uncontrolled hypertension (BP \> 200/110 mmHg) * Inability to walk on the treadmill * Major lower limb amputation * Adult subject to legal protection
Contact & Investigator
Marjolaine Talbot
STUDY CHAIR
Groupement des Hôpitaux de l'Institut Catholique de Lille
Frequently Asked Questions
Who can join the NCT07469020 clinical trial?
This trial is open to participants of all sexes, aged 18 Years or older, studying PAD - Peripheral Arterial Disease. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT07469020 currently recruiting?
Yes, NCT07469020 is actively recruiting participants. Contact the research team at marie-laure.gervais@chu-rennes.fr for enrollment information.
Where is the NCT07469020 trial being conducted?
This trial is being conducted at Lille, France, Paris, France, Rennes, France.
Who is sponsoring the NCT07469020 clinical trial?
NCT07469020 is sponsored by Rennes University Hospital. The principal investigator is Marjolaine Talbot at Groupement des Hôpitaux de l'Institut Catholique de Lille. The trial plans to enroll 49 participants.